A phase?3, randomized, double-blind, Placebo-controlled study to evaluate the efficacy and safety of orally administered deucric

A phase?3, randomized, double-blind, Placebo-controlled study to evaluate the efficacy and safety of orally administered deucrictibant extended-release tablet for Prophylaxis against angioedema attacks in adolescents and adults with hereditary angioedema.

Abierta

Código protocolo: PHA022121-C305
Código EudraCT: _
Grupo de investigación: Enfermedades Sistémicas
Servicio: Medicina Interna
Investigador/a principal: Guilarte Clavero, Mar
Patología: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
Fase: Fase III